← Back to Search
Toward The Establishment Of Standardized In Vitro Tests For Lipid-based Formulations. 2. The Effect Of Bile Salt Concentration And Drug Loading On The Performance Of Type I, II, IIIA, IIIB, And IV Formulations During In Vitro Digestion.
H. Williams, M. U. Anby, P. Sassene, Karen Kleberg, Jean-Claude Bakala-N’Goma, Marilyn Calderone, V. Jannin, A. Igonin, Anette Partheil, D. Marchaud, Eduardo Jule, J. Vertommen, M. Maio, Ross D. Blundell, H. Benameur, F. Carrière, A. Müllertz, C. Pouton, C. H. Porter
Published 2012 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
The LFCS Consortium was established to develop standardized in vitro tests for lipid-based formulations (LBFs) and to examine the utility of these tests to probe the fundamental mechanisms that underlie LBF performance. In this publication, the impact of bile salt (sodium taurodeoxycholate, NaTDC) concentration and drug loading on the ability of a range of representative LBFs to generate and sustain drug solubilization and supersaturation during in vitro digestion testing has been explored and a common driver of the potential for drug precipitation identified. Danazol was used as a model poorly water-soluble drug throughout. In general, increasing NaTDC concentrations increased the digestion of the most lipophilic LBFs and promoted lipid (and drug) trafficking from poorly dispersed oil phases to the aqueous colloidal phase (AP(DIGEST)). High NaTDC concentrations showed some capacity to reduce drug precipitation, although, at NaTDC concentrations ≥3 mM, NaTDC effects on either digestion or drug solubilization were modest. In contrast, increasing drug load had a marked impact on drug solubilization. For LBFs containing long-chain lipids, drug precipitation was limited even at drug loads approaching saturation in the formulation and concentrations of solubilized drug in AP(DIGEST) increased with increased drug load. For LBFs containing medium-chain lipids, however, significant precipitation was evident, especially at higher drug loads. Across all formulations a remarkably consistent trend emerged such that the likelihood of precipitation was almost entirely dependent on the maximum supersaturation ratio (SR(M)) attained on initiation of digestion. SR(M) defines the supersaturation "pressure" in the system and is calculated from the maximum attainable concentration in the AP(DIGEST) (assuming zero precipitation), divided by the solubility of the drug in the colloidal phases formed post digestion. For LBFs where phase separation of oil phases did not occur, a threshold value for SR(M) was evident, regardless of formulation composition and drug solubilization reduced markedly above SR(M) > 2.5. The threshold SR(M) may prove to be an effective tool in discriminating between LBFs based on performance.
This paper references
Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole.
Michiel van Speybroeck (2010)
Influence of Surfactants on Lipase Fat Digestion in a Model Gastro-intestinal System
P. Reis (2008)
Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations.
Héctor R Guzmán (2007)
Lipid-based formulations for intestinal lymphatic delivery.
C. O'Driscoll (2002)
Evaluation of the in‐vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products
L. Sek (2002)
Characterization of Fluids from the Stomach and Proximal Jejunum in Men and Women
A. Lindahl (2004)
Influence of lipid composition and drug load on the In Vitro performance of self-nanoemulsifying drug delivery systems.
N. Thomas (2012)
Nucleation and crystal growth in supersaturated solutions of a model drug.
Lennart Lindfors (2008)
The effect of oral lipids and circulating lipoproteins on the metabolism of drugs
Jigar P. Patel (2009)
Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs
Jean F Cuiné (2006)
Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters.
S. Fernandez (2007)
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility
D. B. Warren (2010)
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
C. Pouton (2008)
Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs.
Jean F Cuiné (2008)
Adsorption of polar lipids at the water-oil interface.
P. Reis (2008)
Kinetics of crystal nucleation in silicate glasses
P. James (1985)
Application of Dissolution/Permeation System for Evaluation of Formulation Effect on Oral Absorption of Poorly Water-Soluble Drugs in Drug Development
M. Kataoka (2011)
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
J. Brouwers (2009)
Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells.
T. Lindmark (1998)
Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering.
D. B. Warren (2011)
The effects of excipients on transporter mediated absorption.
J. Goole (2010)
Lipid-based formulations: exploring the link between in vitro supersaturation and in vivo exposure
C. H. Porter (2011)
Competition between lipases and monoglycerides at interfaces.
P. Reis (2008)
Poorly soluble marketed drugs display solvation limited solubility.
C. Bergström (2007)
AN EXAMINATION OF THE INTERPLAY BETWEEN ENTEROCYTE-BASED METABOLISM AND LYMPHATIC DRUG TRANSPORT IN THE RAT
Natalie L Trevaskis (2006)
Transitions in the internal structure of lipid droplets during fat digestion
S. Salentinig (2011)
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.
Greg A Kossena (2003)
Rate of Nucleation in Condensed Systems
D. Turnbull (1949)
Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases.
S. Fernandez (2008)
Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies.
P. Constantinides (2007)
Lipase reaction at interfaces as self-limiting processes
Pedro Reis (2009)
A formulation-enabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeys.
Po-Chang Chiang (2011)
Low Dose Lipid Formulations: Effects on Gastric Emptying and Biliary Secretion
Greg A Kossena (2007)
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
C. H. Porter (2008)
Effect of degree, type, and position of unsaturation on the pKa of long-chain fatty acids.
J. R. Kanicky (2002)
Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum.
M. Armand (1996)
Lipases at interfaces: a review.
P. Reis (2009)
Characterization and optimization of AMG 517 supersaturatable self-emulsifying drug delivery system (S-SEDDS) for improved oral absorption.
Ping Gao (2009)
Solubilization and Wetting Effects of Bile Salts on the Dissolution of Steroids
V. Bakatselou (2004)
Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo.
A. Müllertz (2012)
Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations
A. Kaukonen (2004)
Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
C. Pouton (2000)
In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14
S. Fernandez (2009)
Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule.
D. Cistola (1988)
Self-assembled structures and pKa value of oleic acid in systems of biological relevance.
S. Salentinig (2010)
Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.
H. Williams (2012)
Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
K. Mohsin (2009)
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.
M. U. Anby (2012)
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆
Natalie L Trevaskis (2008)
Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview.
D. R. Friesen (2008)
Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
C. Pouton (2006)
Approaches for the development of solid and semi-solid lipid-based formulations.
V. Jannin (2008)
Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.
Y. E. Arnold (2011)
This paper is referenced by
An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
M. U. Anby (2014)
Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
M. Salim (2018)
Solid lipid nanoparticles modified with amphipathic chitosan derivatives for improved stability in the gastrointestinal tract
Suping Qiu (2018)
In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
R. Devraj (2013)
Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
H. Williams (2013)
Drug-excipient-shell interactions using thermoplastic starch-based capsules for oral lipid-based drug delivery
Philosophisch-naturwissenschaftlichen Fakultät (2014)
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC.
Y. Tsume (2014)
In Vitro Lipolysis Data Does Not Adequately Predict the In Vivo Performance of Lipid-Based Drug Delivery Systems Containing Fenofibrate
N. Thomas (2014)
Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity.
V. Jannin (2015)
Variations in gastrointestinal lipases, pH and bile acid levels with food intake, age and diseases: Possible impact on oral lipid-based drug delivery systems.
S. Amara (2019)
Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro
Janneke Keemink (2019)
Effect of pH and Ionic Strength on the Solubility of Quinoline: Back-to-Basics
M. Carvajal (2019)
Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
Claire L McEvoy (2017)
Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
H. Williams (2018)
Lipids in the Stomach – Implications for the Evaluation of Food Effects on Oral Drug Absorption
M. Koziolek (2017)
Factors affecting the bioaccessibility of β-carotene in lipid-based microcapsules: Digestive conditions, the composition, structure and physical state of microcapsules
Quanquan Lin (2017)
years of oral lipid-based formulations : Provenance , progress and future perspectives ☆
O. Feeney (2016)
Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
N. Trasi (2015)
Drug supersaturation during formulation digestion, including real-time analytical approaches.
M. Kuentz (2018)
Size characterization of lipid-based self-emulsifying pharmaceutical excipients during lipolysis using Taylor dispersion analysis with fluorescence detection.
J. Chamieh (2018)
The Modern Pharmaceutical Development Challenge: BCS Class II and IV Drugs
Gregory K. Webster (2017)
Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate
Hayley B Schultz (2020)
Models for Predicting Drug Absorption From Oral Lipid-Based Formulations
Linda C Alskär (2015)
Development, Optimization, Characterization and Impact of In vitro Lipolysis on Drug Release of Telmisartan Loaded SMEDDS
R. Kaushik (2019)
Supersaturation as a driving force for drug absorption from colloidal lipid species in the intestine
Yan Yan Yeap (2013)
Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Linda C Alskär (2019)
The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
Aggelos Charalabidis (2019)
In vitro models for the prediction of in vivo performance of oral dosage forms.
Edmund S. Kostewicz (2014)
Strategies to Address Low Drug Solubility in Discovery and Development
H. Williams (2013)
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems
Heejun Park (2020)
Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
Linda Persson (2013)
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
O. Feeney (2014)See more